nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Sumatriptan—ABCG2—lung cancer	0.00394	0.287	CrCbGaD
Naratriptan—Eletriptan—CYP2A6—lung cancer	0.00357	0.26	CrCbGaD
Naratriptan—Almotriptan—CYP2E1—lung cancer	0.00325	0.237	CrCbGaD
Naratriptan—Sumatriptan—ABCB1—lung cancer	0.00164	0.12	CrCbGaD
Naratriptan—Eletriptan—ABCB1—lung cancer	0.00133	0.0967	CrCbGaD
Naratriptan—Skin disorder—Etoposide—lung cancer	0.000405	0.000466	CcSEcCtD
Naratriptan—Dry skin—Doxorubicin—lung cancer	0.000403	0.000464	CcSEcCtD
Naratriptan—Hyperhidrosis—Etoposide—lung cancer	0.000403	0.000464	CcSEcCtD
Naratriptan—Feeling abnormal—Gemcitabine—lung cancer	0.000402	0.000463	CcSEcCtD
Naratriptan—Shock—Paclitaxel—lung cancer	0.000402	0.000463	CcSEcCtD
Naratriptan—Dizziness—Vinorelbine—lung cancer	0.000402	0.000463	CcSEcCtD
Naratriptan—Nervous system disorder—Paclitaxel—lung cancer	0.000401	0.000462	CcSEcCtD
Naratriptan—Photosensitivity reaction—Methotrexate—lung cancer	0.000401	0.000462	CcSEcCtD
Naratriptan—Thrombocytopenia—Paclitaxel—lung cancer	0.0004	0.000461	CcSEcCtD
Naratriptan—Skin disorder—Paclitaxel—lung cancer	0.000397	0.000457	CcSEcCtD
Naratriptan—Body temperature increased—Irinotecan—lung cancer	0.000396	0.000456	CcSEcCtD
Naratriptan—Hyperhidrosis—Paclitaxel—lung cancer	0.000395	0.000455	CcSEcCtD
Naratriptan—Pneumonia—Methotrexate—lung cancer	0.000394	0.000454	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Cisplatin—lung cancer	0.000393	0.000452	CcSEcCtD
Naratriptan—Anaemia—Docetaxel—lung cancer	0.000392	0.000452	CcSEcCtD
Naratriptan—Drowsiness—Methotrexate—lung cancer	0.000391	0.000451	CcSEcCtD
Naratriptan—Depression—Methotrexate—lung cancer	0.00039	0.00045	CcSEcCtD
Naratriptan—Hypotension—Etoposide—lung cancer	0.000389	0.000449	CcSEcCtD
Naratriptan—Gastritis—Doxorubicin—lung cancer	0.000389	0.000448	CcSEcCtD
Naratriptan—Pain—Cisplatin—lung cancer	0.000389	0.000448	CcSEcCtD
Naratriptan—Vomiting—Vinorelbine—lung cancer	0.000386	0.000445	CcSEcCtD
Naratriptan—Body temperature increased—Gemcitabine—lung cancer	0.000386	0.000444	CcSEcCtD
Naratriptan—Rash—Vinorelbine—lung cancer	0.000383	0.000441	CcSEcCtD
Naratriptan—Dermatitis—Vinorelbine—lung cancer	0.000383	0.000441	CcSEcCtD
Naratriptan—Hypotension—Paclitaxel—lung cancer	0.000382	0.00044	CcSEcCtD
Naratriptan—Headache—Vinorelbine—lung cancer	0.000381	0.000438	CcSEcCtD
Naratriptan—Syncope—Docetaxel—lung cancer	0.000381	0.000438	CcSEcCtD
Naratriptan—Asthma—Doxorubicin—lung cancer	0.00038	0.000438	CcSEcCtD
Naratriptan—Sweating—Methotrexate—lung cancer	0.000375	0.000432	CcSEcCtD
Naratriptan—Palpitations—Docetaxel—lung cancer	0.000375	0.000432	CcSEcCtD
Naratriptan—Feeling abnormal—Cisplatin—lung cancer	0.000375	0.000432	CcSEcCtD
Naratriptan—Paraesthesia—Etoposide—lung cancer	0.000374	0.000431	CcSEcCtD
Naratriptan—Loss of consciousness—Docetaxel—lung cancer	0.000373	0.00043	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000372	0.000429	CcSEcCtD
Naratriptan—Dyspnoea—Etoposide—lung cancer	0.000372	0.000428	CcSEcCtD
Naratriptan—Somnolence—Etoposide—lung cancer	0.00037	0.000427	CcSEcCtD
Naratriptan—Cough—Docetaxel—lung cancer	0.00037	0.000427	CcSEcCtD
Naratriptan—Angina pectoris—Doxorubicin—lung cancer	0.00037	0.000427	CcSEcCtD
Naratriptan—Hypersensitivity—Irinotecan—lung cancer	0.000369	0.000425	CcSEcCtD
Naratriptan—Convulsion—Docetaxel—lung cancer	0.000368	0.000424	CcSEcCtD
Naratriptan—Paraesthesia—Paclitaxel—lung cancer	0.000367	0.000423	CcSEcCtD
Naratriptan—Bronchitis—Doxorubicin—lung cancer	0.000366	0.000421	CcSEcCtD
Naratriptan—Dyspnoea—Paclitaxel—lung cancer	0.000364	0.00042	CcSEcCtD
Naratriptan—Somnolence—Paclitaxel—lung cancer	0.000363	0.000419	CcSEcCtD
Naratriptan—Myalgia—Docetaxel—lung cancer	0.000361	0.000416	CcSEcCtD
Naratriptan—Arthralgia—Docetaxel—lung cancer	0.000361	0.000416	CcSEcCtD
Naratriptan—Nausea—Vinorelbine—lung cancer	0.000361	0.000416	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Etoposide—lung cancer	0.00036	0.000415	CcSEcCtD
Naratriptan—Body temperature increased—Cisplatin—lung cancer	0.00036	0.000414	CcSEcCtD
Naratriptan—Asthenia—Irinotecan—lung cancer	0.000359	0.000414	CcSEcCtD
Naratriptan—Fatigue—Etoposide—lung cancer	0.000359	0.000414	CcSEcCtD
Naratriptan—Pain—Etoposide—lung cancer	0.000356	0.000411	CcSEcCtD
Naratriptan—Constipation—Etoposide—lung cancer	0.000356	0.000411	CcSEcCtD
Naratriptan—Dry mouth—Docetaxel—lung cancer	0.000353	0.000407	CcSEcCtD
Naratriptan—Haemoglobin—Methotrexate—lung cancer	0.000353	0.000407	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000353	0.000406	CcSEcCtD
Naratriptan—Fatigue—Paclitaxel—lung cancer	0.000352	0.000406	CcSEcCtD
Naratriptan—Haemorrhage—Methotrexate—lung cancer	0.000351	0.000405	CcSEcCtD
Naratriptan—Pollakiuria—Doxorubicin—lung cancer	0.000351	0.000405	CcSEcCtD
Naratriptan—Asthenia—Gemcitabine—lung cancer	0.00035	0.000403	CcSEcCtD
Naratriptan—Constipation—Paclitaxel—lung cancer	0.000349	0.000403	CcSEcCtD
Naratriptan—Pain—Paclitaxel—lung cancer	0.000349	0.000403	CcSEcCtD
Naratriptan—Confusional state—Docetaxel—lung cancer	0.000349	0.000402	CcSEcCtD
Naratriptan—Photosensitivity reaction—Doxorubicin—lung cancer	0.000347	0.0004	CcSEcCtD
Naratriptan—Anaphylactic shock—Docetaxel—lung cancer	0.000346	0.000399	CcSEcCtD
Naratriptan—Oedema—Docetaxel—lung cancer	0.000346	0.000399	CcSEcCtD
Naratriptan—Pruritus—Gemcitabine—lung cancer	0.000345	0.000398	CcSEcCtD
Naratriptan—Infection—Docetaxel—lung cancer	0.000344	0.000396	CcSEcCtD
Naratriptan—Feeling abnormal—Etoposide—lung cancer	0.000343	0.000396	CcSEcCtD
Naratriptan—Hyperglycaemia—Doxorubicin—lung cancer	0.000343	0.000395	CcSEcCtD
Naratriptan—Diarrhoea—Irinotecan—lung cancer	0.000343	0.000395	CcSEcCtD
Naratriptan—Pneumonia—Doxorubicin—lung cancer	0.000341	0.000393	CcSEcCtD
Naratriptan—Shock—Docetaxel—lung cancer	0.000341	0.000393	CcSEcCtD
Naratriptan—Nervous system disorder—Docetaxel—lung cancer	0.00034	0.000391	CcSEcCtD
Naratriptan—Thrombocytopenia—Docetaxel—lung cancer	0.000339	0.000391	CcSEcCtD
Naratriptan—Drowsiness—Doxorubicin—lung cancer	0.000339	0.00039	CcSEcCtD
Naratriptan—Feeling abnormal—Paclitaxel—lung cancer	0.000337	0.000388	CcSEcCtD
Naratriptan—Skin disorder—Docetaxel—lung cancer	0.000336	0.000388	CcSEcCtD
Naratriptan—Hypersensitivity—Cisplatin—lung cancer	0.000335	0.000386	CcSEcCtD
Naratriptan—Diarrhoea—Gemcitabine—lung cancer	0.000334	0.000385	CcSEcCtD
Naratriptan—Neuropathy peripheral—Doxorubicin—lung cancer	0.000332	0.000383	CcSEcCtD
Naratriptan—Dizziness—Irinotecan—lung cancer	0.000331	0.000382	CcSEcCtD
Naratriptan—Urticaria—Etoposide—lung cancer	0.000331	0.000381	CcSEcCtD
Naratriptan—Body temperature increased—Etoposide—lung cancer	0.000329	0.00038	CcSEcCtD
Naratriptan—Tinnitus—Methotrexate—lung cancer	0.000328	0.000377	CcSEcCtD
Naratriptan—Asthenia—Cisplatin—lung cancer	0.000326	0.000376	CcSEcCtD
Naratriptan—Cardiac disorder—Methotrexate—lung cancer	0.000326	0.000376	CcSEcCtD
Naratriptan—Sweating—Doxorubicin—lung cancer	0.000325	0.000374	CcSEcCtD
Naratriptan—Urticaria—Paclitaxel—lung cancer	0.000325	0.000374	CcSEcCtD
Naratriptan—Hypotension—Docetaxel—lung cancer	0.000324	0.000373	CcSEcCtD
Naratriptan—Body temperature increased—Paclitaxel—lung cancer	0.000323	0.000372	CcSEcCtD
Naratriptan—Angiopathy—Methotrexate—lung cancer	0.000319	0.000367	CcSEcCtD
Naratriptan—Vomiting—Irinotecan—lung cancer	0.000319	0.000367	CcSEcCtD
Naratriptan—Sinusitis—Doxorubicin—lung cancer	0.000318	0.000366	CcSEcCtD
Naratriptan—Immune system disorder—Methotrexate—lung cancer	0.000317	0.000366	CcSEcCtD
Naratriptan—Rash—Irinotecan—lung cancer	0.000316	0.000364	CcSEcCtD
Naratriptan—Dermatitis—Irinotecan—lung cancer	0.000316	0.000364	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000316	0.000364	CcSEcCtD
Naratriptan—Chills—Methotrexate—lung cancer	0.000315	0.000363	CcSEcCtD
Naratriptan—Headache—Irinotecan—lung cancer	0.000314	0.000362	CcSEcCtD
Naratriptan—Diarrhoea—Cisplatin—lung cancer	0.000311	0.000359	CcSEcCtD
Naratriptan—Paraesthesia—Docetaxel—lung cancer	0.000311	0.000358	CcSEcCtD
Naratriptan—Alopecia—Methotrexate—lung cancer	0.00031	0.000358	CcSEcCtD
Naratriptan—Vomiting—Gemcitabine—lung cancer	0.00031	0.000358	CcSEcCtD
Naratriptan—Bradycardia—Doxorubicin—lung cancer	0.00031	0.000357	CcSEcCtD
Naratriptan—Dyspnoea—Docetaxel—lung cancer	0.000309	0.000356	CcSEcCtD
Naratriptan—Somnolence—Docetaxel—lung cancer	0.000308	0.000355	CcSEcCtD
Naratriptan—Rash—Gemcitabine—lung cancer	0.000308	0.000355	CcSEcCtD
Naratriptan—Dermatitis—Gemcitabine—lung cancer	0.000307	0.000354	CcSEcCtD
Naratriptan—Hypersensitivity—Etoposide—lung cancer	0.000307	0.000354	CcSEcCtD
Naratriptan—Erythema—Methotrexate—lung cancer	0.000306	0.000352	CcSEcCtD
Naratriptan—Haemoglobin—Doxorubicin—lung cancer	0.000306	0.000352	CcSEcCtD
Naratriptan—Headache—Gemcitabine—lung cancer	0.000306	0.000352	CcSEcCtD
Naratriptan—Haemorrhage—Doxorubicin—lung cancer	0.000304	0.000351	CcSEcCtD
Naratriptan—Hypoaesthesia—Doxorubicin—lung cancer	0.000303	0.000349	CcSEcCtD
Naratriptan—Hypersensitivity—Paclitaxel—lung cancer	0.000301	0.000347	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Docetaxel—lung cancer	0.000299	0.000344	CcSEcCtD
Naratriptan—Asthenia—Etoposide—lung cancer	0.000299	0.000344	CcSEcCtD
Naratriptan—Fatigue—Docetaxel—lung cancer	0.000299	0.000344	CcSEcCtD
Naratriptan—Nausea—Irinotecan—lung cancer	0.000298	0.000343	CcSEcCtD
Naratriptan—Pain—Docetaxel—lung cancer	0.000296	0.000341	CcSEcCtD
Naratriptan—Constipation—Docetaxel—lung cancer	0.000296	0.000341	CcSEcCtD
Naratriptan—Pruritus—Etoposide—lung cancer	0.000295	0.00034	CcSEcCtD
Naratriptan—Asthenia—Paclitaxel—lung cancer	0.000293	0.000338	CcSEcCtD
Naratriptan—Nausea—Gemcitabine—lung cancer	0.00029	0.000334	CcSEcCtD
Naratriptan—Vomiting—Cisplatin—lung cancer	0.000289	0.000333	CcSEcCtD
Naratriptan—Pruritus—Paclitaxel—lung cancer	0.000289	0.000333	CcSEcCtD
Naratriptan—Vision blurred—Methotrexate—lung cancer	0.000288	0.000332	CcSEcCtD
Naratriptan—Rash—Cisplatin—lung cancer	0.000287	0.00033	CcSEcCtD
Naratriptan—Dermatitis—Cisplatin—lung cancer	0.000287	0.00033	CcSEcCtD
Naratriptan—Feeling abnormal—Docetaxel—lung cancer	0.000285	0.000329	CcSEcCtD
Naratriptan—Diarrhoea—Etoposide—lung cancer	0.000285	0.000329	CcSEcCtD
Naratriptan—Ill-defined disorder—Methotrexate—lung cancer	0.000284	0.000327	CcSEcCtD
Naratriptan—Tinnitus—Doxorubicin—lung cancer	0.000284	0.000327	CcSEcCtD
Naratriptan—Anaemia—Methotrexate—lung cancer	0.000283	0.000326	CcSEcCtD
Naratriptan—Cardiac disorder—Doxorubicin—lung cancer	0.000282	0.000325	CcSEcCtD
Naratriptan—Diarrhoea—Paclitaxel—lung cancer	0.00028	0.000322	CcSEcCtD
Naratriptan—Angiopathy—Doxorubicin—lung cancer	0.000276	0.000318	CcSEcCtD
Naratriptan—Malaise—Methotrexate—lung cancer	0.000276	0.000318	CcSEcCtD
Naratriptan—Dizziness—Etoposide—lung cancer	0.000276	0.000318	CcSEcCtD
Naratriptan—Immune system disorder—Doxorubicin—lung cancer	0.000275	0.000317	CcSEcCtD
Naratriptan—Vertigo—Methotrexate—lung cancer	0.000275	0.000317	CcSEcCtD
Naratriptan—Body temperature increased—Docetaxel—lung cancer	0.000274	0.000315	CcSEcCtD
Naratriptan—Chills—Doxorubicin—lung cancer	0.000273	0.000315	CcSEcCtD
Naratriptan—Arrhythmia—Doxorubicin—lung cancer	0.000272	0.000313	CcSEcCtD
Naratriptan—Dizziness—Paclitaxel—lung cancer	0.00027	0.000311	CcSEcCtD
Naratriptan—Nausea—Cisplatin—lung cancer	0.00027	0.000311	CcSEcCtD
Naratriptan—Alopecia—Doxorubicin—lung cancer	0.000269	0.00031	CcSEcCtD
Naratriptan—Cough—Methotrexate—lung cancer	0.000267	0.000308	CcSEcCtD
Naratriptan—Convulsion—Methotrexate—lung cancer	0.000265	0.000305	CcSEcCtD
Naratriptan—Vomiting—Etoposide—lung cancer	0.000265	0.000305	CcSEcCtD
Naratriptan—Erythema—Doxorubicin—lung cancer	0.000265	0.000305	CcSEcCtD
Naratriptan—Rash—Etoposide—lung cancer	0.000263	0.000303	CcSEcCtD
Naratriptan—Dermatitis—Etoposide—lung cancer	0.000262	0.000302	CcSEcCtD
Naratriptan—Headache—Etoposide—lung cancer	0.000261	0.000301	CcSEcCtD
Naratriptan—Arthralgia—Methotrexate—lung cancer	0.00026	0.0003	CcSEcCtD
Naratriptan—Myalgia—Methotrexate—lung cancer	0.00026	0.0003	CcSEcCtD
Naratriptan—Vomiting—Paclitaxel—lung cancer	0.00026	0.000299	CcSEcCtD
Naratriptan—Rash—Paclitaxel—lung cancer	0.000258	0.000297	CcSEcCtD
Naratriptan—Dermatitis—Paclitaxel—lung cancer	0.000257	0.000297	CcSEcCtD
Naratriptan—Discomfort—Methotrexate—lung cancer	0.000257	0.000296	CcSEcCtD
Naratriptan—Headache—Paclitaxel—lung cancer	0.000256	0.000295	CcSEcCtD
Naratriptan—Hypersensitivity—Docetaxel—lung cancer	0.000255	0.000294	CcSEcCtD
Naratriptan—Muscle spasms—Doxorubicin—lung cancer	0.000255	0.000293	CcSEcCtD
Naratriptan—Confusional state—Methotrexate—lung cancer	0.000252	0.00029	CcSEcCtD
Naratriptan—Anaphylactic shock—Methotrexate—lung cancer	0.00025	0.000288	CcSEcCtD
Naratriptan—Vision blurred—Doxorubicin—lung cancer	0.00025	0.000288	CcSEcCtD
Naratriptan—Asthenia—Docetaxel—lung cancer	0.000248	0.000286	CcSEcCtD
Naratriptan—Infection—Methotrexate—lung cancer	0.000248	0.000286	CcSEcCtD
Naratriptan—Nausea—Etoposide—lung cancer	0.000248	0.000285	CcSEcCtD
Naratriptan—Ill-defined disorder—Doxorubicin—lung cancer	0.000246	0.000283	CcSEcCtD
Naratriptan—Pruritus—Docetaxel—lung cancer	0.000245	0.000282	CcSEcCtD
Naratriptan—Nervous system disorder—Methotrexate—lung cancer	0.000245	0.000282	CcSEcCtD
Naratriptan—Anaemia—Doxorubicin—lung cancer	0.000245	0.000282	CcSEcCtD
Naratriptan—Thrombocytopenia—Methotrexate—lung cancer	0.000244	0.000282	CcSEcCtD
Naratriptan—Agitation—Doxorubicin—lung cancer	0.000243	0.00028	CcSEcCtD
Naratriptan—Nausea—Paclitaxel—lung cancer	0.000243	0.00028	CcSEcCtD
Naratriptan—Skin disorder—Methotrexate—lung cancer	0.000242	0.000279	CcSEcCtD
Naratriptan—Hyperhidrosis—Methotrexate—lung cancer	0.000241	0.000278	CcSEcCtD
Naratriptan—Malaise—Doxorubicin—lung cancer	0.000239	0.000275	CcSEcCtD
Naratriptan—Vertigo—Doxorubicin—lung cancer	0.000238	0.000274	CcSEcCtD
Naratriptan—Syncope—Doxorubicin—lung cancer	0.000237	0.000274	CcSEcCtD
Naratriptan—Diarrhoea—Docetaxel—lung cancer	0.000237	0.000273	CcSEcCtD
Naratriptan—Palpitations—Doxorubicin—lung cancer	0.000234	0.00027	CcSEcCtD
Naratriptan—Hypotension—Methotrexate—lung cancer	0.000233	0.000269	CcSEcCtD
Naratriptan—Loss of consciousness—Doxorubicin—lung cancer	0.000233	0.000268	CcSEcCtD
Naratriptan—Cough—Doxorubicin—lung cancer	0.000231	0.000266	CcSEcCtD
Naratriptan—Convulsion—Doxorubicin—lung cancer	0.000229	0.000264	CcSEcCtD
Naratriptan—Dizziness—Docetaxel—lung cancer	0.000229	0.000264	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000227	0.000262	CcSEcCtD
Naratriptan—Myalgia—Doxorubicin—lung cancer	0.000225	0.00026	CcSEcCtD
Naratriptan—Arthralgia—Doxorubicin—lung cancer	0.000225	0.00026	CcSEcCtD
Naratriptan—Anxiety—Doxorubicin—lung cancer	0.000225	0.000259	CcSEcCtD
Naratriptan—Paraesthesia—Methotrexate—lung cancer	0.000224	0.000258	CcSEcCtD
Naratriptan—Discomfort—Doxorubicin—lung cancer	0.000223	0.000257	CcSEcCtD
Naratriptan—Dyspnoea—Methotrexate—lung cancer	0.000223	0.000256	CcSEcCtD
Naratriptan—Somnolence—Methotrexate—lung cancer	0.000222	0.000256	CcSEcCtD
Naratriptan—Dry mouth—Doxorubicin—lung cancer	0.00022	0.000254	CcSEcCtD
Naratriptan—Vomiting—Docetaxel—lung cancer	0.00022	0.000254	CcSEcCtD
Naratriptan—Rash—Docetaxel—lung cancer	0.000218	0.000252	CcSEcCtD
Naratriptan—Dermatitis—Docetaxel—lung cancer	0.000218	0.000251	CcSEcCtD
Naratriptan—Confusional state—Doxorubicin—lung cancer	0.000218	0.000251	CcSEcCtD
Naratriptan—Headache—Docetaxel—lung cancer	0.000217	0.00025	CcSEcCtD
Naratriptan—Anaphylactic shock—Doxorubicin—lung cancer	0.000216	0.000249	CcSEcCtD
Naratriptan—Oedema—Doxorubicin—lung cancer	0.000216	0.000249	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Methotrexate—lung cancer	0.000215	0.000248	CcSEcCtD
Naratriptan—Fatigue—Methotrexate—lung cancer	0.000215	0.000248	CcSEcCtD
Naratriptan—Infection—Doxorubicin—lung cancer	0.000215	0.000247	CcSEcCtD
Naratriptan—Pain—Methotrexate—lung cancer	0.000213	0.000246	CcSEcCtD
Naratriptan—Shock—Doxorubicin—lung cancer	0.000213	0.000245	CcSEcCtD
Naratriptan—Nervous system disorder—Doxorubicin—lung cancer	0.000212	0.000244	CcSEcCtD
Naratriptan—Thrombocytopenia—Doxorubicin—lung cancer	0.000212	0.000244	CcSEcCtD
Naratriptan—Skin disorder—Doxorubicin—lung cancer	0.00021	0.000242	CcSEcCtD
Naratriptan—Hyperhidrosis—Doxorubicin—lung cancer	0.000209	0.000241	CcSEcCtD
Naratriptan—Nausea—Docetaxel—lung cancer	0.000206	0.000237	CcSEcCtD
Naratriptan—Feeling abnormal—Methotrexate—lung cancer	0.000206	0.000237	CcSEcCtD
Naratriptan—Hypotension—Doxorubicin—lung cancer	0.000202	0.000233	CcSEcCtD
Naratriptan—Urticaria—Methotrexate—lung cancer	0.000198	0.000228	CcSEcCtD
Naratriptan—Body temperature increased—Methotrexate—lung cancer	0.000197	0.000227	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000197	0.000227	CcSEcCtD
Naratriptan—Paraesthesia—Doxorubicin—lung cancer	0.000194	0.000224	CcSEcCtD
Naratriptan—Dyspnoea—Doxorubicin—lung cancer	0.000193	0.000222	CcSEcCtD
Naratriptan—Somnolence—Doxorubicin—lung cancer	0.000192	0.000221	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000187	0.000215	CcSEcCtD
Naratriptan—Fatigue—Doxorubicin—lung cancer	0.000186	0.000215	CcSEcCtD
Naratriptan—Pain—Doxorubicin—lung cancer	0.000185	0.000213	CcSEcCtD
Naratriptan—Constipation—Doxorubicin—lung cancer	0.000185	0.000213	CcSEcCtD
Naratriptan—Hypersensitivity—Methotrexate—lung cancer	0.000184	0.000212	CcSEcCtD
Naratriptan—Asthenia—Methotrexate—lung cancer	0.000179	0.000206	CcSEcCtD
Naratriptan—Feeling abnormal—Doxorubicin—lung cancer	0.000178	0.000205	CcSEcCtD
Naratriptan—Pruritus—Methotrexate—lung cancer	0.000177	0.000203	CcSEcCtD
Naratriptan—Urticaria—Doxorubicin—lung cancer	0.000172	0.000198	CcSEcCtD
Naratriptan—Body temperature increased—Doxorubicin—lung cancer	0.000171	0.000197	CcSEcCtD
Naratriptan—Diarrhoea—Methotrexate—lung cancer	0.000171	0.000197	CcSEcCtD
Naratriptan—Dizziness—Methotrexate—lung cancer	0.000165	0.00019	CcSEcCtD
Naratriptan—Hypersensitivity—Doxorubicin—lung cancer	0.000159	0.000183	CcSEcCtD
Naratriptan—Vomiting—Methotrexate—lung cancer	0.000159	0.000183	CcSEcCtD
Naratriptan—Rash—Methotrexate—lung cancer	0.000157	0.000181	CcSEcCtD
Naratriptan—Dermatitis—Methotrexate—lung cancer	0.000157	0.000181	CcSEcCtD
Naratriptan—Headache—Methotrexate—lung cancer	0.000156	0.00018	CcSEcCtD
Naratriptan—Asthenia—Doxorubicin—lung cancer	0.000155	0.000179	CcSEcCtD
Naratriptan—Pruritus—Doxorubicin—lung cancer	0.000153	0.000176	CcSEcCtD
Naratriptan—Nausea—Methotrexate—lung cancer	0.000148	0.000171	CcSEcCtD
Naratriptan—Diarrhoea—Doxorubicin—lung cancer	0.000148	0.00017	CcSEcCtD
Naratriptan—Dizziness—Doxorubicin—lung cancer	0.000143	0.000165	CcSEcCtD
Naratriptan—Vomiting—Doxorubicin—lung cancer	0.000137	0.000158	CcSEcCtD
Naratriptan—Rash—Doxorubicin—lung cancer	0.000136	0.000157	CcSEcCtD
Naratriptan—Dermatitis—Doxorubicin—lung cancer	0.000136	0.000157	CcSEcCtD
Naratriptan—Headache—Doxorubicin—lung cancer	0.000135	0.000156	CcSEcCtD
Naratriptan—Nausea—Doxorubicin—lung cancer	0.000128	0.000148	CcSEcCtD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CB—lung cancer	4.9e-05	0.000414	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CG—lung cancer	4.87e-05	0.000411	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAP2K1—lung cancer	4.85e-05	0.000409	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF1R—lung cancer	4.83e-05	0.000408	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CD—lung cancer	4.81e-05	0.000407	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APP—lung cancer	4.81e-05	0.000406	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH3—lung cancer	4.81e-05	0.000406	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CXCL8—lung cancer	4.81e-05	0.000406	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGF9—lung cancer	4.77e-05	0.000403	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—PIK3CA—lung cancer	4.77e-05	0.000403	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HES1—lung cancer	4.74e-05	0.000401	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF1R—lung cancer	4.73e-05	0.000399	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—KRAS—lung cancer	4.71e-05	0.000398	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CXCL8—lung cancer	4.71e-05	0.000398	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CYP1A1—lung cancer	4.69e-05	0.000396	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ERCC2—lung cancer	4.65e-05	0.000393	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—RAF1—lung cancer	4.65e-05	0.000393	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HES1—lung cancer	4.65e-05	0.000392	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—POMC—lung cancer	4.64e-05	0.000392	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—IL2—lung cancer	4.59e-05	0.000388	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—JUNB—lung cancer	4.56e-05	0.000385	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—RAF1—lung cancer	4.56e-05	0.000385	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CB—lung cancer	4.54e-05	0.000384	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—IL2—lung cancer	4.5e-05	0.00038	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CB—lung cancer	4.45e-05	0.000376	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CG—lung cancer	4.42e-05	0.000374	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCL8—lung cancer	4.37e-05	0.000369	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ERBB3—lung cancer	4.34e-05	0.000366	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PIK3CA—lung cancer	4.33e-05	0.000366	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MDM2—lung cancer	4.31e-05	0.000364	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—RAF1—lung cancer	4.3e-05	0.000363	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CD—lung cancer	4.28e-05	0.000362	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CXCL8—lung cancer	4.27e-05	0.000361	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ERBB2—lung cancer	4.25e-05	0.000359	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ERBB3—lung cancer	4.25e-05	0.000359	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—POMC—lung cancer	4.21e-05	0.000356	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MTOR—lung cancer	4.2e-05	0.000355	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CB—lung cancer	4.2e-05	0.000355	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL2—lung cancer	4.17e-05	0.000352	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TERT—lung cancer	4.16e-05	0.000351	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STK11—lung cancer	4.14e-05	0.00035	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6R—lung cancer	4.11e-05	0.000347	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL2—lung cancer	4.09e-05	0.000345	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TERT—lung cancer	4.07e-05	0.000344	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FGFR1—lung cancer	4.04e-05	0.000341	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCL8—lung cancer	4.03e-05	0.000341	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOA1—lung cancer	4.03e-05	0.00034	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HRAS—lung cancer	4.01e-05	0.000338	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FOXO3—lung cancer	3.99e-05	0.000337	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HIF1A—lung cancer	3.98e-05	0.000336	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FGFR1—lung cancer	3.95e-05	0.000334	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—MAP2K1—lung cancer	3.91e-05	0.000331	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—AKT1—lung cancer	3.9e-05	0.000329	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HIF1A—lung cancer	3.89e-05	0.000329	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CD—lung cancer	3.89e-05	0.000328	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CASP3—lung cancer	3.86e-05	0.000326	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL2—lung cancer	3.85e-05	0.000326	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOA1—lung cancer	3.84e-05	0.000324	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—lung cancer	3.83e-05	0.000324	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KDR—lung cancer	3.8e-05	0.000321	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCND1—lung cancer	3.76e-05	0.000317	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOA1—lung cancer	3.76e-05	0.000317	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—JUN—lung cancer	3.75e-05	0.000317	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AVP—lung cancer	3.74e-05	0.000316	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CB—lung cancer	3.73e-05	0.000315	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KDR—lung cancer	3.72e-05	0.000314	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CG—lung cancer	3.68e-05	0.00031	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MMP9—lung cancer	3.65e-05	0.000308	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CDKN1A—lung cancer	3.63e-05	0.000307	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PTEN—lung cancer	3.63e-05	0.000306	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1R—lung cancer	3.6e-05	0.000304	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCL8—lung cancer	3.59e-05	0.000303	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HES1—lung cancer	3.54e-05	0.000299	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—AKT1—lung cancer	3.54e-05	0.000299	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CG—lung cancer	3.5e-05	0.000296	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APC—lung cancer	3.5e-05	0.000296	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KIT—lung cancer	3.5e-05	0.000296	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—NRAS—lung cancer	3.5e-05	0.000296	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—POMC—lung cancer	3.5e-05	0.000296	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—RAF1—lung cancer	3.47e-05	0.000293	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EGF—lung cancer	3.46e-05	0.000292	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EP300—lung cancer	3.46e-05	0.000292	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KIT—lung cancer	3.43e-05	0.00029	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CG—lung cancer	3.43e-05	0.00029	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APC—lung cancer	3.43e-05	0.00029	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—NRAS—lung cancer	3.43e-05	0.00029	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IL2—lung cancer	3.43e-05	0.00029	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CREBBP—lung cancer	3.41e-05	0.000288	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EGF—lung cancer	3.39e-05	0.000286	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CB—lung cancer	3.39e-05	0.000286	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SRC—lung cancer	3.36e-05	0.000284	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—MAPK3—lung cancer	3.35e-05	0.000283	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—POMC—lung cancer	3.33e-05	0.000282	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—BRAF—lung cancer	3.29e-05	0.000278	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—MAPK3—lung cancer	3.28e-05	0.000277	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—VEGFA—lung cancer	3.28e-05	0.000277	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—POMC—lung cancer	3.26e-05	0.000276	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCL8—lung cancer	3.26e-05	0.000275	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6R—lung cancer	3.25e-05	0.000275	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CREBBP—lung cancer	3.25e-05	0.000274	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—STAT3—lung cancer	3.24e-05	0.000274	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NRAS—lung cancer	3.24e-05	0.000273	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ERBB3—lung cancer	3.24e-05	0.000273	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CD—lung cancer	3.23e-05	0.000273	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—BRAF—lung cancer	3.22e-05	0.000272	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—EGFR—lung cancer	3.19e-05	0.00027	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ALB—lung cancer	3.19e-05	0.000269	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6R—lung cancer	3.18e-05	0.000269	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CREBBP—lung cancer	3.18e-05	0.000269	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—EGFR—lung cancer	3.12e-05	0.000264	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL2—lung cancer	3.11e-05	0.000263	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TERT—lung cancer	3.1e-05	0.000262	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAP2K1—lung cancer	3.1e-05	0.000262	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAPK3—lung cancer	3.1e-05	0.000262	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CD—lung cancer	3.08e-05	0.00026	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3CA—lung cancer	3.05e-05	0.000258	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAP2K1—lung cancer	3.03e-05	0.000256	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CD—lung cancer	3.01e-05	0.000255	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—KRAS—lung cancer	3.01e-05	0.000255	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MYC—lung cancer	3.01e-05	0.000255	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGFR1—lung cancer	3.01e-05	0.000254	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CA—lung cancer	2.99e-05	0.000252	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HIF1A—lung cancer	2.97e-05	0.000251	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—KRAS—lung cancer	2.95e-05	0.000249	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EGFR—lung cancer	2.95e-05	0.000249	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOA1—lung cancer	2.86e-05	0.000242	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KDR—lung cancer	2.84e-05	0.00024	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CB—lung cancer	2.82e-05	0.000238	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—lung cancer	2.79e-05	0.000236	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—KRAS—lung cancer	2.78e-05	0.000235	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CA—lung cancer	2.77e-05	0.000234	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MDM2—lung cancer	2.76e-05	0.000233	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RAF1—lung cancer	2.75e-05	0.000232	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ERBB2—lung cancer	2.72e-05	0.00023	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CA—lung cancer	2.71e-05	0.000229	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MDM2—lung cancer	2.7e-05	0.000228	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RAF1—lung cancer	2.69e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MTOR—lung cancer	2.68e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CB—lung cancer	2.68e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ERBB2—lung cancer	2.66e-05	0.000225	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MTOR—lung cancer	2.63e-05	0.000222	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CB—lung cancer	2.63e-05	0.000222	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APC—lung cancer	2.61e-05	0.000221	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CG—lung cancer	2.61e-05	0.000221	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KIT—lung cancer	2.61e-05	0.000221	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—NRAS—lung cancer	2.61e-05	0.000221	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EGF—lung cancer	2.58e-05	0.000218	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCL8—lung cancer	2.58e-05	0.000218	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HRAS—lung cancer	2.56e-05	0.000216	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CA—lung cancer	2.56e-05	0.000216	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL8—lung cancer	2.53e-05	0.000213	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HRAS—lung cancer	2.51e-05	0.000212	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—MAPK3—lung cancer	2.5e-05	0.000211	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AKT1—lung cancer	2.49e-05	0.00021	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—POMC—lung cancer	2.49e-05	0.00021	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TP53—lung cancer	2.47e-05	0.000209	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CASP3—lung cancer	2.47e-05	0.000209	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL2—lung cancer	2.46e-05	0.000208	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—BRAF—lung cancer	2.46e-05	0.000207	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—lung cancer	2.45e-05	0.000207	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AKT1—lung cancer	2.44e-05	0.000206	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTEN—lung cancer	2.43e-05	0.000206	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6R—lung cancer	2.43e-05	0.000205	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CREBBP—lung cancer	2.42e-05	0.000205	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CASP3—lung cancer	2.42e-05	0.000204	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL2—lung cancer	2.41e-05	0.000204	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCND1—lung cancer	2.4e-05	0.000203	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—lung cancer	2.4e-05	0.000203	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—JUN—lung cancer	2.4e-05	0.000203	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—EGFR—lung cancer	2.38e-05	0.000201	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HRAS—lung cancer	2.37e-05	0.0002	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCND1—lung cancer	2.35e-05	0.000199	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—JUN—lung cancer	2.35e-05	0.000198	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP9—lung cancer	2.33e-05	0.000197	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CDKN1A—lung cancer	2.32e-05	0.000196	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—EP300—lung cancer	2.32e-05	0.000196	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTEN—lung cancer	2.32e-05	0.000196	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAP2K1—lung cancer	2.31e-05	0.000195	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CD—lung cancer	2.3e-05	0.000194	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP9—lung cancer	2.28e-05	0.000193	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CDKN1A—lung cancer	2.28e-05	0.000192	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CA—lung cancer	2.27e-05	0.000192	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTEN—lung cancer	2.27e-05	0.000192	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—lung cancer	2.27e-05	0.000191	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AKT1—lung cancer	2.26e-05	0.000191	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—KRAS—lung cancer	2.25e-05	0.00019	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AKT1—lung cancer	2.22e-05	0.000187	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EP300—lung cancer	2.21e-05	0.000187	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EP300—lung cancer	2.17e-05	0.000183	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SRC—lung cancer	2.15e-05	0.000182	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SRC—lung cancer	2.11e-05	0.000178	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—VEGFA—lung cancer	2.09e-05	0.000177	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AKT1—lung cancer	2.09e-05	0.000177	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—STAT3—lung cancer	2.07e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NRAS—lung cancer	2.07e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	2.07e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MDM2—lung cancer	2.06e-05	0.000174	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—VEGFA—lung cancer	2.05e-05	0.000173	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RAF1—lung cancer	2.05e-05	0.000173	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—STAT3—lung cancer	2.03e-05	0.000172	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ERBB2—lung cancer	2.03e-05	0.000171	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NRAS—lung cancer	2.03e-05	0.000171	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MTOR—lung cancer	2e-05	0.000169	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CB—lung cancer	2e-05	0.000169	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAPK3—lung cancer	1.98e-05	0.000167	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAPK3—lung cancer	1.94e-05	0.000164	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MYC—lung cancer	1.93e-05	0.000163	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL8—lung cancer	1.92e-05	0.000163	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HRAS—lung cancer	1.91e-05	0.000161	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MYC—lung cancer	1.89e-05	0.000159	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EGFR—lung cancer	1.89e-05	0.000159	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT1—lung cancer	1.86e-05	0.000157	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EGFR—lung cancer	1.85e-05	0.000156	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CASP3—lung cancer	1.84e-05	0.000156	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL2—lung cancer	1.84e-05	0.000155	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—lung cancer	1.83e-05	0.000155	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCND1—lung cancer	1.79e-05	0.000151	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—JUN—lung cancer	1.79e-05	0.000151	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KRAS—lung cancer	1.78e-05	0.00015	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KRAS—lung cancer	1.74e-05	0.000147	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP9—lung cancer	1.74e-05	0.000147	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CDKN1A—lung cancer	1.73e-05	0.000146	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTEN—lung cancer	1.73e-05	0.000146	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CA—lung cancer	1.72e-05	0.000145	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT1—lung cancer	1.69e-05	0.000143	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EP300—lung cancer	1.65e-05	0.000139	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CA—lung cancer	1.64e-05	0.000138	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SRC—lung cancer	1.6e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CA—lung cancer	1.6e-05	0.000135	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TP53—lung cancer	1.58e-05	0.000134	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VEGFA—lung cancer	1.56e-05	0.000132	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TP53—lung cancer	1.55e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STAT3—lung cancer	1.55e-05	0.000131	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NRAS—lung cancer	1.54e-05	0.00013	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HRAS—lung cancer	1.51e-05	0.000128	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HRAS—lung cancer	1.48e-05	0.000125	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAPK3—lung cancer	1.48e-05	0.000125	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—lung cancer	1.45e-05	0.000122	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MYC—lung cancer	1.44e-05	0.000121	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—lung cancer	1.42e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EGFR—lung cancer	1.41e-05	0.000119	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AKT1—lung cancer	1.4e-05	0.000118	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT1—lung cancer	1.34e-05	0.000113	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KRAS—lung cancer	1.33e-05	0.000112	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT1—lung cancer	1.31e-05	0.000111	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.22e-05	0.000103	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TP53—lung cancer	1.18e-05	9.97e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HRAS—lung cancer	1.13e-05	9.54e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—lung cancer	1.08e-05	9.13e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT1—lung cancer	9.97e-06	8.42e-05	CbGpPWpGaD
